Effect of vitamin D on platelet increase in chronic idiopathic thrombocytopenic purpura

Vitamin D levels in children with chronic idiopathic thrombocytopenic purpura and the effect of vitamin D supplementation on platelet increase

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

IRCT

Registry ID

IRCT20220817055737N1

Enrollment

Registered

2022-12-23

Start date

2022-02-19

Completion date

Unknown

Last updated

2023-02-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Chronic Idiopathic Thrombocytopenic Purpura. Immune thrombocytopenic purpura

Interventions

Intervention group: In patients with vitamin D levels below 30 mg/dl, vitamin D supplementation will be administered at 400 units per day for children under 1 year of age and 600 units per day for chi

Eligibility

Sex/Gender

All

Age

No minimum to 18 Years

Inclusion criteria

Inclusion criteria: Diagnosis of chronic ITP Giving informed consent vitamin D level lower than 30 mg/dl

Exclusion criteria

Exclusion criteria: Incomplete demographic data Being reluctant to participate in the study History of taking vitamin D supplements for the previous 3 months at a therapeutic dose Change in the dosage of the medications taken Severe and dangerous drop in platelet levels and need for hospitalization

Design outcomes

Primary

Measure	Time frame
Platelet counts prior to and following supplementation with vitamin D. Timepoint: Blood platelet levels were measured at the beginning of the trial and 3 & 9 months following the initiation of vitamin D supplementation. Method of measurement: Blood platelet levels.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactRoham Sarmadian

Arak University of Medical Sciences

rsarmadian@yahoo.com+98 86 3147 3521

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026